Document is current
Any future updates will be listed below
-
Authors
Nguyen, Trang https://orcid.org/0009-0004-9413-5965
Koesterer, Ryan
Haydarlou, Poeya https://orcid.org/0009-0000-3938-3377
Dornbos, Peter
Yoshiji, Satoshi https://orcid.org/0000-0001-8863-2413
Llamas, Alex
Jang, Dongkeun
Smadbeck, Patrick
Moriondo, Annie
Hoang, Quy https://orcid.org/0000-0002-7140-6097
Ruebenacker, Oliver
Bezzina, Connie R. https://orcid.org/0000-0002-0633-3514
Ellinor, Patrick https://orcid.org/0000-0002-2067-0533
Jurgens, Sean J. https://orcid.org/0000-0002-1605-9782
Burtt, Noël P.
Flannick, Jason https://orcid.org/0000-0002-3618-795X
- License Information
-
More Information
Article History
Received: 27 March 2025
Accepted: 9 April 2026
First Online: 8 May 2026
Competing interests
: As of April 2026, P.D. is an employee and stockholder of Regeneron Pharmaceuticals. The other authors declare no competing interests.
